Recently approved by the US Food and Drug Administration, catheter-directed thrombolysis improved heart function and clot ...
Agomab Therapeutics has now secured a US Food and Drug Administration (FDA) orphan drug designation for IPF treatment ...
Ioana Preston, MD, highlights treatment considerations for managing PAH in specific patient populations and discusses the ...
LONG BEACH, California — A small fraction of patients with pulmonary embolism (PE) who are eligible for advanced therapies ...
Insmed Incorporated a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare ...
Smoking And Chronic Obstructive Pulmonary Disease: How Does Smoking Trigger COPD and Management Tips
Heres how smoking triggers Chronic Obstructive Pulmonary Disease a progressive lung condition and learn effective management ...
Supervised pulmonary rehabilitation after severe COVID-19 can improve pulmonary function, exercise performance, and quality of life.
Global Chronic Obstructive Pulmonary Disease Industry is forecasted to register 4.4% CAGR from 2023 to 2033 to reach US$ 33.2 ...
Dr Deepak Prajapat revealed, “Numerous variables increase the likelihood of developing pulmonary TB. Diabetes, a disorder ...
Global Pulmonary Fibrosis Biomarker Market to Grow at 4.4% CAGR, Reaching USD6,538.4 Million by 2034
The global Pulmonary Fibrosis Biomarker market is set for steady growth, with sales projected to accelerate at a compound ...
Microsoft Start Health on MSN11d
Questions About Pulmonary Edema? Harvard Health Publishing Has Answers.What causes pulmonary edema? Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years ...
DELHI, DELHI, INDIA, June 6, 2024 /EINPresswire / -- DelveInsight's 'Pulmonary Hypertension Associated with Interstitial Lung Disease-Market Insights, Epidemiology, and market Forecast–2034' report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback